阳普医疗
(300030)
| 流通市值：11.07亿 | | | 总市值：12.65亿 |
| 流通股本：2.71亿 | | | 总股本：3.09亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 472,397,898.67 | 319,761,957.04 | 158,563,957.54 | 710,768,471.36 |
| 营业收入 | 472,397,898.67 | 319,761,957.04 | 158,563,957.54 | 710,768,471.36 |
| 二、营业总成本 | 477,874,723.34 | 321,221,243.56 | 155,199,816.17 | 752,781,655.05 |
| 营业成本 | 283,155,990.39 | 193,817,846.82 | 96,620,009.01 | 446,348,568.6 |
| 税金及附加 | 6,088,819.16 | 4,695,867.19 | 1,842,365.88 | 7,923,811.28 |
| 销售费用 | 79,180,674.33 | 50,577,556.48 | 22,281,713.29 | 126,047,338.83 |
| 管理费用 | 72,612,981.08 | 47,158,237.96 | 20,140,136.38 | 113,351,367.71 |
| 研发费用 | 26,661,891.75 | 17,984,539.75 | 9,259,547.98 | 43,665,063.73 |
| 财务费用 | 10,174,366.63 | 6,987,195.36 | 5,056,043.63 | 15,445,504.9 |
| 其中:利息费用 | 11,153,443.06 | 7,836,910.69 | 4,059,192.45 | 19,699,211.81 |
| 其中:利息收入 | 1,682,589.99 | 1,185,640.79 | 495,960.62 | 2,454,254.55 |
| 加:公允价值变动收益 | - | - | - | -5,953,429.78 |
| 加:投资收益 | 7,542,670.78 | 10,874,840.74 | 10,528,707.6 | -47,142,215.49 |
| 资产处置收益 | 4,527,871.16 | -450,888.56 | -512,825.81 | 438,733.01 |
| 资产减值损失(新) | -3,802,201.26 | 462,758.2 | - | -117,891,517.39 |
| 信用减值损失(新) | -1,077,040.57 | -1,077,040.57 | 400 | -10,700,856.58 |
| 其他收益 | 6,327,844.9 | 4,856,078.48 | 2,382,009.45 | 10,421,139.94 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 8,042,320.34 | 13,206,461.77 | 15,762,432.61 | -212,841,329.98 |
| 加:营业外收入 | 99,353.29 | 88,479.57 | 136,421.48 | 279,318.2 |
| 减:营业外支出 | 324,619.49 | 121,838.25 | 204.94 | 1,735,321.69 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 7,817,054.14 | 13,173,103.09 | 15,898,649.15 | -214,297,333.47 |
| 减:所得税费用 | 2,266,625.56 | 1,616,290.67 | 1,728,803.13 | -21,006,205.66 |
| 六、净利润 | 5,550,428.58 | 11,556,812.42 | 14,169,846.02 | -193,291,127.81 |
| 持续经营净利润 | 5,550,428.58 | 11,556,812.42 | 14,169,846.02 | -193,291,127.81 |
| 归属于母公司股东的净利润 | 3,184,966.3 | 10,464,418.4 | 13,633,861.49 | -198,300,074.8 |
| 少数股东损益 | 2,365,462.28 | 1,092,394.02 | 535,984.53 | 5,008,946.99 |
| (一)基本每股收益 | 0.01 | 0.03 | 0.04 | -0.64 |
| (二)稀释每股收益 | 0.01 | 0.03 | 0.04 | -0.64 |
| 八、其他综合收益 | -1,164.93 | 3,015.82 | 1,405.29 | -5,025,853.32 |
| 归属于母公司股东的其他综合收益 | -1,164.93 | 3,015.82 | 1,405.29 | -5,025,853.32 |
| 九、综合收益总额 | 5,549,263.65 | 11,559,828.24 | 14,171,251.31 | -198,316,981.13 |
| 归属于母公司股东的综合收益总额 | 3,183,801.37 | 10,467,434.22 | 13,635,266.78 | -203,325,928.12 |
| 归属于少数股东的综合收益总额 | 2,365,462.28 | 1,092,394.02 | 535,984.53 | 5,008,946.99 |
| 公告日期 | 2023-10-27 | 2023-08-30 | 2023-04-27 | 2023-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |